Our findings reveal a significant involvement of both Aldh1a1+ and Calb1+ SNc DANs in motor control and learning, highlighting both molecularly distinct SNc DAN subtypes as potential therapeutic targets for treating PD-related movement disorders. The gene discussed is ALDH1A1; the disease is Parkinson disease.